1. Home
  2. ACXP vs AREB Comparison

ACXP vs AREB Comparison

Compare ACXP & AREB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACXP
  • AREB
  • Stock Information
  • Founded
  • ACXP 2017
  • AREB 2014
  • Country
  • ACXP United States
  • AREB United States
  • Employees
  • ACXP N/A
  • AREB N/A
  • Industry
  • ACXP Biotechnology: Pharmaceutical Preparations
  • AREB Plastic Products
  • Sector
  • ACXP Health Care
  • AREB Industrials
  • Exchange
  • ACXP Nasdaq
  • AREB Nasdaq
  • Market Cap
  • ACXP 6.8M
  • AREB 6.7M
  • IPO Year
  • ACXP 2021
  • AREB N/A
  • Fundamental
  • Price
  • ACXP $5.08
  • AREB $1.46
  • Analyst Decision
  • ACXP Strong Buy
  • AREB
  • Analyst Count
  • ACXP 3
  • AREB 0
  • Target Price
  • ACXP $143.67
  • AREB N/A
  • AVG Volume (30 Days)
  • ACXP 1.6M
  • AREB 8.8M
  • Earning Date
  • ACXP 11-12-2025
  • AREB 11-14-2025
  • Dividend Yield
  • ACXP N/A
  • AREB N/A
  • EPS Growth
  • ACXP N/A
  • AREB N/A
  • EPS
  • ACXP N/A
  • AREB N/A
  • Revenue
  • ACXP N/A
  • AREB $9,474,958.00
  • Revenue This Year
  • ACXP N/A
  • AREB N/A
  • Revenue Next Year
  • ACXP N/A
  • AREB N/A
  • P/E Ratio
  • ACXP N/A
  • AREB N/A
  • Revenue Growth
  • ACXP N/A
  • AREB N/A
  • 52 Week Low
  • ACXP $3.80
  • AREB $1.22
  • 52 Week High
  • ACXP $39.00
  • AREB $1,947.50
  • Technical
  • Relative Strength Index (RSI)
  • ACXP 38.27
  • AREB 42.17
  • Support Level
  • ACXP $6.24
  • AREB $1.22
  • Resistance Level
  • ACXP $6.80
  • AREB $3.62
  • Average True Range (ATR)
  • ACXP 0.52
  • AREB 0.52
  • MACD
  • ACXP -0.31
  • AREB -0.34
  • Stochastic Oscillator
  • ACXP 0.00
  • AREB 5.83

About ACXP Acurx Pharmaceuticals Inc.

Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.

About AREB American Rebel Holdings Inc.

American Rebel Holdings Inc develops self-defense, safe storage, and patriotic product areas using a wholesale distribution network, utilizing personal appearances, musical venue performances, as well as e-commerce and television. It designs, manufactures, and markets concealed carry products. It offers products ranging in Backpacks, jackets, coats, and Others. The Company views its operations and manages its business as one operating segment engaged in patriotic goods, comprised of safes, soft goods, and beer.

Share on Social Networks: